Lucid Diagnostics (LUCD) Total Liabilities (2020 - 2026)

Lucid Diagnostics has reported Total Liabilities for 7 years, with the latest figure at $30.1 million in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities fell 21.2% year-over-year to $30.1 million; the trailing twelve-month figure through Mar 2026 stood at $30.1 million (down 21.2% YoY), and the FY2025 full-year result was $29.5 million, up 16.53% from the prior year.
• Total Liabilities for Q1 2026 stood at $30.1 million, up from $29.5 million in the prior quarter.
• The five-year high for Total Liabilities was $38.2 million in Q1 2025, with the low at $9.2 million in Q2 2022.
• Historically, Total Liabilities has averaged $23.1 million across 5 years, with a median of $25.3 million in 2024.
• Annual changes were most pronounced in 2022 — Total Liabilities sank 60.47% — and 2023, when it jumped 212.63%.
• Lucid Diagnostics' Total Liabilities stood at $9.5 million in 2022, then jumped by 212.63% to $29.6 million in 2023, then dropped by 14.39% to $25.3 million in 2024, then gained by 16.53% to $29.5 million in 2025, then gained by 1.94% to $30.1 million in 2026.
• The last three Total Liabilities figures came in at $30.1 million (Q1 2026), $29.5 million (Q4 2025), and $27.4 million (Q3 2025), per Business Quant data.